Quartz Partners, LLC Acurx Pharmaceuticals, Inc. Transaction History
Quartz Partners, LLC
- $165 Billion
- Q1 2025
A detailed history of Quartz Partners, LLC transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Quartz Partners, LLC holds 10,000 shares of ACXP stock, worth $8,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$8,200% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACXP
# of Institutions
27Shares Held
3.49MCall Options Held
100Put Options Held
0-
Sabby Management, LLC Upper Saddle River, NJ2.04MShares$1.68 Million6.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA529KShares$434,0660.0% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$300,5920.08% of portfolio
-
Geode Capital Management, LLC Boston, MA171KShares$140,6190.0% of portfolio
-
Morgan Stanley New York, NY106KShares$87,0840.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $9.48M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...